Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Reboxetine Adjuvant Therapy and Cognitive and Behavioral Measures

NCT00409201 is registered in ClinicalTrials.gov with Abarbanel Mental Health Center as lead sponsor.

NCT NCT00409201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00409201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Reboxetine Adjuvant Therapy and Cognitive and Behavioral Measures
Lead sponsor
Abarbanel Mental Health Center
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2006
Completion date
November 30, 2006
Enrollment
30
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia